Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer

Por Aghajanian, Carol, Goff, Barbara, Nycum, Lawrence R., Wang, Yan V., Husain, Amreen, Blank, Stephanie V.
Publicado no Gynecol Oncol (2015)

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian,...

Por Aghajanian, Carol, Blank, Stephanie V., Goff, Barbara A., Judson, Patricia L., Teneriello, Michael G., Husain, Amreen, Sovak, Mika A., Yi, Jing, Nycum, Lawrence R.
Publicado em 2012